These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23647681)

  • 1. Evidence for regulation of UDP-glucuronosyltransferase (UGT) 1A1 protein expression and activity via DNA methylation in healthy human livers.
    Yasar U; Greenblatt DJ; Guillemette C; Court MH
    J Pharm Pharmacol; 2013 Jun; 65(6):874-83. PubMed ID: 23647681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system.
    Court MH
    Drug Metab Rev; 2010 Feb; 42(1):209-24. PubMed ID: 19821798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure.
    Court MH; Freytsis M; Wang X; Peter I; Guillemette C; Hazarika S; Duan SX; Greenblatt DJ; Lee WM;
    J Pharmacol Exp Ther; 2013 May; 345(2):297-307. PubMed ID: 23408116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism.
    Iyer L; Hall D; Das S; Mortell MA; Ramírez J; Kim S; Di Rienzo A; Ratain MJ
    Clin Pharmacol Ther; 1999 May; 65(5):576-82. PubMed ID: 10340924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells.
    Bélanger AS; Tojcic J; Harvey M; Guillemette C
    BMC Mol Biol; 2010 Jan; 11():9. PubMed ID: 20096102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank.
    Fisher MB; Vandenbranden M; Findlay K; Burchell B; Thummel KE; Hall SD; Wrighton SA
    Pharmacogenetics; 2000 Nov; 10(8):727-39. PubMed ID: 11186135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomes.
    Rouguieg K; Picard N; Sauvage FL; Gaulier JM; Marquet P
    Drug Metab Dispos; 2010 Jan; 38(1):40-5. PubMed ID: 19841060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes.
    Peterkin VC; Bauman JN; Goosen TC; Menning L; Man MZ; Paulauskis JD; Williams JA; Myrand SP
    Br J Clin Pharmacol; 2007 Oct; 64(4):458-68. PubMed ID: 17555467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone Modifications Regulate the Developmental Expression of Human Hepatic UDP-Glucuronosyltransferase 1A1.
    Nie YL; Meng XG; Liu JY; Yan L; Wang P; Bi HZ; Kan QC; Zhang LR
    Drug Metab Dispos; 2017 Dec; 45(12):1372-1378. PubMed ID: 29025858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the effects of common UDP glucuronosyltransferase (UGT) 1A6 and UGT1A1 polymorphisms on cis- and trans-resveratrol glucuronidation.
    Iwuchukwu OF; Ajetunmobi J; Ung D; Nagar S
    Drug Metab Dispos; 2009 Aug; 37(8):1726-32. PubMed ID: 19406951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin.
    Fujiwara R; Sumida K; Kutsuno Y; Sakamoto M; Itoh T
    Drug Metab Pharmacokinet; 2015 Feb; 30(1):82-8. PubMed ID: 25760534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1.
    Watanabe Y; Nakajima M; Ohashi N; Kume T; Yokoi T
    Drug Metab Dispos; 2003 May; 31(5):589-95. PubMed ID: 12695347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms in the TATA box and upstream phenobarbital-responsive enhancer module of the UGT1A1 promoter have combined effects on UDP-glucuronosyltransferase 1A1 transcription mediated by constitutive androstane receptor, pregnane X receptor, or glucocorticoid receptor in human liver.
    Li Y; Buckley D; Wang S; Klaassen CD; Zhong XB
    Drug Metab Dispos; 2009 Sep; 37(9):1978-86. PubMed ID: 19541828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation is a crucial factor in the repression of UGT1A1 expression in the human kidney.
    Oda S; Fukami T; Yokoi T; Nakajima M
    Drug Metab Dispos; 2013 Oct; 41(10):1738-43. PubMed ID: 23401472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups.
    Innocenti F; Grimsley C; Das S; Ramírez J; Cheng C; Kuttab-Boulos H; Ratain MJ; Di Rienzo A
    Pharmacogenetics; 2002 Dec; 12(9):725-33. PubMed ID: 12464801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10.
    Watanabe Y; Nakajima M; Yokoi T
    Drug Metab Dispos; 2002 Dec; 30(12):1462-9. PubMed ID: 12433820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5'-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation.
    Krishnaswamy S; Hao Q; Al-Rohaimi A; Hesse LM; von Moltke LL; Greenblatt DJ; Court MH
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1331-9. PubMed ID: 15761114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms.
    Court MH; Duan SX; von Moltke LL; Greenblatt DJ; Patten CJ; Miners JO; Mackenzie PI
    J Pharmacol Exp Ther; 2001 Dec; 299(3):998-1006. PubMed ID: 11714888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: implications for patients with Gilbert's syndrome.
    Peters WH; te Morsche RH; Roelofs HM
    J Hepatol; 2003 Jan; 38(1):3-8. PubMed ID: 12480553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between the UDP-glucuronosyltransferase (UGT1A1) TATAA box polymorphism and carcinogen detoxification phenotype: significantly decreased glucuronidating activity against benzo(a)pyrene-7,8-dihydrodiol(-) in liver microsomes from subjects with the UGT1A1*28 variant.
    Fang JL; Lazarus P
    Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):102-9. PubMed ID: 14744740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.